Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Rebetol, ribavirin
print preview
bookmark
share with colleague
General Information
Company
Merck & Co. Inc.
Description
Combination of intron A interferon (IFN) alfa-2b and ribavirin
Molecular Target
Type I interferon (IFN) receptor
Mechanism of Action
Type I interferon (IFN) receptor agonist
Latest Stage of Development
Marketed
Indication
Hepatitis C virus (HCV)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information